Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Dihydrochalcone. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel one-pot method for spiroisoxazolines from dihydrochalcones. High yield, mild conditions, cost-effective pharma intermediate manufacturing.
Novel synthesis of 4'-hydroxy-4,6'-dimethoxydihydrochalcone via Pd/C hydrogenation offers high purity and scalable pharmaceutical intermediate production.
Novel non-hydrogenation route for 2'-hydroxydihydrochalcone using 2-phenyl-benzothiazoline. Safe, scalable, cost-effective API intermediate manufacturing.
Patent CN111925282A reveals mild catalytic reduction for high-purity pharmaceutical intermediates. Enhances supply chain safety and reduces manufacturing costs significantly.
Novel one-pot synthesis of spiroisoxazolines from dihydrochalcones. High yield, mild conditions, cost-effective pharmaceutical intermediate manufacturing.